Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05092087
Other study ID # N202103134
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 21, 2021
Est. completion date May 31, 2021

Study information

Verified date April 2021
Source Taipei Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to investigate the frequency of personalized nutrition counseling's effect on individual cardiovascular risk factors. The study collected 110 to 150 cases data, including a regular blood test, blood glucose, blood lipid, liver panel, and inflammatory factors. The enrolled cases were classified into two groups according to the subjects' duration of consultation: those who completed the consultation and subsequent tests in >24 weeks were in the control group, whereas those who completed the consultation and subsequent tests in <24 weeks were in the test group. The effectiveness of nutrition consultation toward managing cardiovascular disease risk factors and its correlation with the subjects' frequency of following the consultations was analyzed using the pre- and post-consultation data. It was found that personalized nutrition consultation significantly improved the subjects' risk factors of cardiovascular diseases, and that the treatment group showed a greater improvement than the control group which who require over 24 weeks to complete all consultation sessions.


Description:

The most of interventional studies on nutrition consultation have generally emphasized on the extent to which the diet composition can prevent chronic diseases or provide improvement. Although dietitians play an important role in health education for the primary prevention of chronic disease, their individuals dietary consultation results are mostly focused on weight loss and blood glucose control. However, the effectiveness of nutrition consultation on the prevention of chronic diseases, such as hyperlipidemia, hypertension and cardiovascular diseases, has few been studied. The effectiveness of dietary instructions provided to individuals by dietitians in primary health care institutes is yet to be validated with significant evidence. In addition, nutrition consultation methods, processes, and influencing factors on its results are seldom discussed. Therefore, this study aims to investigate the frequency of personalized nutrition counseling's effect on individual cardiovascular risk factors. The study collected1 10 to 150 cases data who aimed to prevent or improve chronic diseases and had completed eight times individualized nutrition consultations from Bon Vivant Health Lifestyle Management Center, and the pre- and post-consultation data, including a regular blood test, blood glucose, blood lipid, liver panel, and inflammatory factors, will be analyzed. Blood were drawn before and after the first and the last time consultation for biochemical tests; blood pressure and body composition was also measured for comparison. The enrolled cases will be classified into two groups according to the subjects' duration of consultation: those who completed the consultation and subsequent tests in >24 weeks were in the control group, whereas those who completed the consultation and subsequent tests in <24 weeks were in the test group. The effectiveness of nutrition consultation toward managing cardiovascular disease risk factors and its correlation with the subjects' frequency of following the consultations was analyzed using the pre- and post-consultation data. It was found that personalized nutrition consultation significantly improved the subjects' risk factors of cardiovascular diseases, and that the treatment group showed a greater improvement than the control group which who require over 24 weeks to complete all consultation sessions.


Recruitment information / eligibility

Status Completed
Enrollment 129
Est. completion date May 31, 2021
Est. primary completion date May 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Age ? 20 - Anyone of follow: body mass index > 24 systolic blood pressure > 120 mmHg diastolic blood pressure > 80 mmHg triglyceride > 150 mg/dL fasting blood glucose >100 mg/dL Exclusion Criteria: - Age <20 - pregnant - Mental problem - unable to do the measurement of body composition - incomplete the nutritional counseling program

Study Design


Intervention

Behavioral:
nutrition counseling
nutrition counseling

Locations

Country Name City State
Taiwan Taipei Medical University Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary body weight body weight in kilograms baseline, pre-intervention
Primary body weight body weight in kilograms immediately after the intervention
Primary height height in meters baseline, pre-intervention
Primary height height in meters immediately after the intervention
Primary body mass index body mass index in kg/m^2 baseline, pre-intervention
Primary body mass index body mass index in kg/m^2 immediately after the intervention
Primary body fat body fat in ratio baseline, pre-intervention
Primary body fat body fat in ratio immediately after the intervention
Primary The concentration of blood triglyceride blood triglyceride in mg/dL baseline, pre-intervention
Primary The concentration of blood total cholesterol blood total cholesterol in mg/dL within one week after the intervention
Primary The concentration of blood low density lipoprotein-cholesterol blood blood low density lipoprotein-cholesterol in mg/dL baseline, pre-intervention
Primary The concentration of blood low density lipoprotein-cholesterol blood blood low density lipoprotein-cholesterol in mg/dL within one week after the intervention
Primary The concentration of blood high density lipoprotein-cholesterol-cholesterol blood high density lipoprotein-cholesterol in mg/dL baseline, pre-intervention
Primary The concentration of blood high density lipoprotein-cholesterol-cholesterol blood high density lipoprotein-cholesterol in mg/dL within one week after the intervention
Primary The concentration of blood high sensitive C-reactive protein blood high sensitive sensitive C-reactive protein in mg/L baseline, pre-intervention
Primary The concentration of blood high sensitive C-reactive protein blood high sensitive sensitive C-reactive protein in mg/L within one week after the intervention
Primary The concentration of blood fasting glucose blood fasting glucose in mg/dL baseline, pre-intervention
Primary The concentration of blood fasting glucose blood fasting glucose in mg/dL within one week after the intervention
Primary blood HbA1C blood HbA1C in percentage baseline, pre-intervention
Primary blood HbA1C blood HbA1C in percentage within one week after the intervention
Primary The concentration of blood insulin blood insulin in mg/dL baseline, pre-intervention
Primary The concentration of blood insulin blood insulin in mg/dL within one week after the intervention
Primary The activity of blood aspartate aminotransferase blood aspartate aminotransferase in U/L baseline, pre-intervention
Primary The activity of blood aspartate aminotransferase blood aspartate aminotransferase in U/L within one week after the intervention
Primary The activity of blood alanine aminotransferase blood alanine aminotransferase in U/L baseline, pre-intervention
Primary The activity of blood alanine aminotransferase blood alanine aminotransferase in U/L within one week after the intervention
Primary The concentration of blood urinary nitrogen (BUN) BUN in mg/L baseline, pre-intervention
Primary The concentration of blood urinary nitrogen (BUN) BUN in mg/L within one week after the intervention
Primary The concentration of blood creatinine BUN in mg/dL baseline, pre-intervention
Primary The concentration of blood creatinine BUN in mg/dL within one week after the intervention
Primary The concentration of blood uric acid blood uric acid in mg/dL baseline, pre-intervention
Primary The concentration of blood uric acid blood uric acid in mg/dL within one week after the intervention
Primary The concentration of blood total protein blood uric acid in mg/dL baseline, pre-intervention
Primary The concentration of blood total protein blood uric acid in mg/dL within one week after the intervention
Primary The concentration of blood albumin blood uric acid in mg/dL baseline, pre-intervention
Primary The concentration of blood albumin blood uric acid in mg/dL within one week after the intervention
Primary The concentration of blood globulin blood uric acid in mg/dL baseline, pre-intervention
Primary The concentration of blood globulin blood uric acid in mg/dL within one week after the intervention
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02248311 - "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population N/A
Completed NCT01604486 - Natural Ischaemic Preconditioning Before First Myocardial Infarction N/A
Active, not recruiting NCT00627029 - Evaluation of Programs of Coordinated Care and Disease Management N/A
Recruiting NCT04336852 - Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function N/A
Not yet recruiting NCT05925699 - National Database of the Virtual Institute of Cerebrovascular Diseases
Recruiting NCT04443439 - Assess the Risk of Cerebrovascular Disease
Recruiting NCT04525144 - EGb 761 in the Syndrome of MCI With Concomitant CVD Phase 2
Completed NCT02553655 - Remote Ischemic Limb Preconditioning In Healthy Volunteers N/A
Recruiting NCT00385385 - RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease Phase 2
Recruiting NCT05247931 - Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
Completed NCT02665585 - Plaque Prolapse Prevention Carotid Artery Stenting (3PCAS) N/A
Recruiting NCT05834673 - VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) Phase 4
Recruiting NCT06115213 - The North Kynouria Project N/A
Recruiting NCT02730065 - Aerobic Dance Training in Small Vessel Disease N/A
Terminated NCT02440646 - Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging
Completed NCT01924312 - Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease N/A
Completed NCT00333164 - Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis Phase 3
Not yet recruiting NCT06241482 - Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care N/A
Enrolling by invitation NCT02694094 - Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
Not yet recruiting NCT04696120 - Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial Phase 2